Health Economics and Outcomes Research (HEOR) Services
Manufacturers, Payers, Providers, Patient groups and Regulators use HEOR as a shared language to guide decisions. Price & patient access to specific medications and technologies and services are a common decision theme. HEOR is a complement to traditional clinical development information.
Management’s need to assess and communicate the economic value of healthcare inventions, processes and decisions using the vocabulary of improved medical outcomes, savings on medical expenditure, or diversion of patients to effective remote care from ER or inpatient care.
FTC provide expertise and experience to boost our client’s resources. MNCs, Midsize and Start-Ups employ FTCs HEOR services for strategy, formulary and protocol optimization, contracting for IDN and AOC programs, New Product Pricing and Disease Model Analysis and market intelligence
FTC Health Economics and Outcomes Research Services
Our clients rely on FTC
Our clients rely on FTC’s
- Industry Segment Expertise for Pricing, Formulary, Government negotiation, Insurance Company negotiation
- Professional project management & reporting
- Rapid project completion
- High utility of our deliverables
HEOR High Utility
FTC HEOR analysis can be tailored for Manufacturers, Payers, Providers, Patient groups and Regulators. This permits full confidence in presentation and negotiation as our clients can know all sides of the analysis.
FTC HEOR complements traditional clinical development information. This provides the full story of a new technologies benefit in the marketplace.
FTC HEOR analysis expands management’s view to the dynamic linkage of healthcare interactions from patient to payer and all resources in between.